-

BUYOUT INVESTIGATION: Kaskela Law LLC Announces Investigation of New Relic (NYSE: NEWR) Buyout: Does $87.00 Per Share Represent Sufficient Cash Out Payment for NEWR Shares?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating the fairness of the recently proposed buyout agreement of New Relic, Inc. (“New Relic”) (NYSE: NEWR) stockholders by private equity firms Francisco Partners and TPG at $87.00 per share.

The $87.00 per share buyout price appears to undervalue New Relic’s shares. Notably, at the time the proposed buyout was negotiated and announced, several stock analysts had assigned price targets on New Relic’s shares well above the $87.00 per share buyout price, including one who had assigned a $113.00 per share price target to the shares. Additionally, Reuters recently reported that “[t]he two private equity firms offered more than $90 per share in cash to acquire New Relic” in May.

The investigation seeks to determine whether $87.00 per share represents maximum achievable cash consideration for New Relic’s shareholders, and whether New Relic’s officers and/or directors breached their fiduciary duties or violated the securities laws by agreeing to sell the company to Francisco Partners and TPG at $87.00 per share.

New Relic stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/new-relic/ , for additional information about this investigation and their legal rights and options with respect this matter.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NYSE:NEWR

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Reservoir Media, Inc. and Encourages Investors to Contact the Firm – RSVR

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Reservoir Media, Inc. (NASDAQ: RSVR) on behalf of the company's shareholders....

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Priority Technology Holdings, Inc. and Encourages Investors to Contact the Firm – PRTH

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is conducting a stockholder investigation into Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority Technology”). The investigation seeks to determine whether Priority Technology and/or the company’s representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Priority Technology shareholders should contact Kaskela Law (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 2...

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...
Back to Newsroom